Shikang Zhao
P.R. China
Tianjin, 300052, China
Tianjin, 300052, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
PD‑1/PD‑L1 immune checkpoint inhibitors in neoadjuvant therapy for solid tumors (Review).
Journal: International journal of oncology
Published: October 07, 2022
Complete disease remission in a TP53 and KRAS co-mutated brain oligometastatic lung cancer patient after immuno-chemotherapy and surgical resection: a case report.
Journal: Translational lung cancer research
Published: June 24, 2021
Expression of RASGRP2 in Lung Adenocarcinoma and Its Effect on Immune Microenvironment
Journal: Zhongguo fei ai za zhi = Chinese journal of lung cancer
Published: June 22, 2021
The KEYNOTE-189 trial as a new paradigm making cure a reality for metastatic non-squamous non-small cell lung cancer.
Journal: Translational lung cancer research
Published: November 19, 2020
Sublobar Resection Versus Lobectomy for Early-Stage Pulmonary Carcinoid Tumors ≤3 cm in Size: A SEER Population-Based Study.
Journal: Annals of surgery
Published: November 16, 2020
A Case of Simultaneously Diagnosed Lung Adenocarcinoma and Endobronchial Inflammatory Myofibroblastic Tumor with Two Distinct Types of ALK Translocation.
Journal: Cancer research and treatment
Published: September 21, 2020
The Impact of Programmed Death-Ligand 1 Expression on the Prognosis of Early Stage Resected Non-Small Cell Lung Cancer: A Meta-Analysis of Literatures.
Journal: Frontiers in oncology
Published: May 31, 2020
Circular RNA Signature in Lung Adenocarcinoma: A MiOncoCirc Database-Based Study and Literature Review.
Journal: Frontiers in oncology
Published: February 04, 2020
Showing 1-10 of 10
Last Updated: 09/26/2026